Consensus Corbus Pharmaceuticals Holdings, Inc.

Equities

CRBP

US21833P3010

Real-time Estimate Cboe BZX Other stock markets 09:22:34 10/05/2024 pm IST			5-day change	1st Jan Change
42.62 ^USD	-2.57%		+9.85%	+605.13%

08/05	Oppenheimer Adjusts Corbus Pharmaceuticals Price Target to $60 From $58, Maintains Outperform Rating	MT
07/05	Corbus Pharmaceuticals Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Evolution of the average Target Price on Corbus Pharmaceuticals Holdings, Inc.

Price target over the last 5 years

History of analyst recommendation changes

72819b62f3f48e59f9621b160d8c4b.HbB8hVpDWLUNJxIurLqYLxzSiuicVuVhqZ3Axc0rnVA.LtcM9DkUE4dIeHtPlNatQ3T_6KDGEZY7-cSF9aZZ3zxMw0_MCDciwHQSZQ~94d3b9098dc06fe1873e705339a10c7a

Analyst Recommendations on Corbus Pharmaceuticals Holdings, Inc.

Oppenheimer Adjusts Corbus Pharmaceuticals Price Target to $60 From $58, Maintains Outperform Rating	08/05	MT
Oppenheimer Adjusts Corbus Pharmaceuticals Price Target to $58 From $51, Maintains Outperform Rating	13/03	MT
Jefferies Upgrades Corbus Pharmaceuticals Holdings to Buy From Hold	06/03	MT
Oppenheimer Adjusts Corbus Pharmaceuticals Price Target to $51 From $20, Maintains Outperform Rating	29/01	MT
Oppenheimer Adjusts Corbus Pharmaceuticals Price Target to $20 From $22, Maintains Outperform Rating	08/11	MT
Oppenheimer Upgrades Corbus Pharmaceuticals to Outperform From Perform, $22 Price Target	10/23/10	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

43.74 USD

Average target price

68 USD

Spread / Average Target

+55.46%

High Price Target

76 USD

Spread / Highest target

+73.75%

Low Price Target

60 USD

Spread / Lowest Target

+37.17%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Corbus Pharmaceuticals Holdings, Inc.

Oppenheimer
Jefferies & Co.

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar